S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL

• S. Stilgenbauer,
• E. Tausch,
• A. W. Roberts,
• M. S. Davids,
• B. Eichhorst,
• M. Hallek,
• P. Hillmen,
• C. Schneider,
• S. Böttcher,
• R. Popovic,
• M. T. Ghanim,
• M. Moran,
• W. J. Sinai,
• X. Wang,
• N. Mukherjee,
• B. Chyla,
• W. G. Wierda,
• J. F. Seymour

Affiliations

S. Stilgenbauer

1 Division of CLL, Internal Medicine III, Ulm University, Ulm, Germany

E. Tausch

1 Division of CLL, Internal Medicine III, Ulm University, Ulm, Germany

A. W. Roberts

2 Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, Australia

M. S. Davids

3 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America

B. Eichhorst

4 Department of Internal Medicine, Center of Integrated Oncology Köln Bonn, University Hospital of Cologne, Cologne, Germany

M. Hallek

4 Department of Internal Medicine, Center of Integrated Oncology Köln Bonn, University Hospital of Cologne, Cologne, Germany

P. Hillmen

5 Leeds Teaching Hospitals, NHS Trust, Leeds, United Kingdom

C. Schneider

1 Division of CLL, Internal Medicine III, Ulm University, Ulm, Germany

S. Böttcher

6 Division of Internal Medicine, Medical Clinic III-Hematology, Oncology and Palliative Medicine, Rostock University Medical Center, Rostock, Germany

R. Popovic

7 AbbVie Inc, North Chicago, IL

M. T. Ghanim

7 AbbVie Inc, North Chicago, IL

M. Moran

7 AbbVie Inc, North Chicago, IL

W. J. Sinai

7 AbbVie Inc, North Chicago, IL

X. Wang

7 AbbVie Inc, North Chicago, IL

N. Mukherjee

7 AbbVie Inc, North Chicago, IL

B. Chyla

7 AbbVie Inc, North Chicago, IL

W. G. Wierda

8 The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America

J. F. Seymour

2 Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, Australia